The perceptions and knowledge of oncology pharmacy practitioners on assisted dying. |
Section 1
Dear participant,
You are being invited to take part in a MPharm final year project. The primary aim of this study is to understand the perceptions and knowledge of oncology/haematology pharmacy practitioner’s on assisted dying. This research is based on the perceptions of oncology/haematology pharmacy practitioners. You have been chosen to take part in this research because you are a pharmacy practitioner working within the oncology/haematology speciality. If you consent to take part, then you will be asked to fill in a questionnaire. The questionnaire consists of three sections, with a total duration of approximately 10 minutes. The first section consists of thirteen statements/questions that you will be asked to rate your agreement to. Section 2 compromises of four case studies and section 3 will be gathering demographics. If you decide not to take part, there will be no disadvantage to you, and we thank you for your time in considering our project. All information collected during the course of the study will be kept strictly confidential and in secure storage. Responses will be anonymised before analysis so that it will not be possible to identify you or any other participant. Only I/we and the project supervisor will have access to this dataset. The Kingston University Faculty of Science, Engineering and Computing Research Ethics Committee have reviewed and approved this study.
You are being invited to take part in a MPharm final year project. The primary aim of this study is to understand the perceptions and knowledge of oncology/haematology pharmacy practitioner’s on assisted dying. This research is based on the perceptions of oncology/haematology pharmacy practitioners. You have been chosen to take part in this research because you are a pharmacy practitioner working within the oncology/haematology speciality. If you consent to take part, then you will be asked to fill in a questionnaire. The questionnaire consists of three sections, with a total duration of approximately 10 minutes. The first section consists of thirteen statements/questions that you will be asked to rate your agreement to. Section 2 compromises of four case studies and section 3 will be gathering demographics. If you decide not to take part, there will be no disadvantage to you, and we thank you for your time in considering our project. All information collected during the course of the study will be kept strictly confidential and in secure storage. Responses will be anonymised before analysis so that it will not be possible to identify you or any other participant. Only I/we and the project supervisor will have access to this dataset. The Kingston University Faculty of Science, Engineering and Computing Research Ethics Committee have reviewed and approved this study.
Contact for further information.
Further information may be obtained from:
Remeesha Razak
K1629076@kingston.ac.uk
Dr Shereen Nabhnai-Gebara
PharmD, BCOP
Penrhyn Road, KT1 2EE
020 84167413
s.nabhani@kingston.ac.uk
Further information may be obtained from:
Remeesha Razak
K1629076@kingston.ac.uk
Dr Shereen Nabhnai-Gebara
PharmD, BCOP
Penrhyn Road, KT1 2EE
020 84167413
s.nabhani@kingston.ac.uk